Page last updated: 2024-10-23

bisoprolol and Leishmaniasis

bisoprolol has been researched along with Leishmaniasis in 1 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferrari, I1
Levin, MJ1
Wallukat, G1
Elies, R1
Lebesgue, D1
Chiale, P1
Elizari, M1
Rosenbaum, M1
Hoebeke, J1

Other Studies

1 other study available for bisoprolol and Leishmaniasis

ArticleYear
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.
    The Journal of experimental medicine, 1995, Jul-01, Volume: 182, Issue:1

    Topics: Amino Acid Sequence; Animals; Animals, Newborn; Antibodies, Protozoan; Antigens, Protozoan; Autoanti

1995